Structure-based discovery of C-2 substituted imidazo-pyrrolopyridine JAK1 inhibitors with improved selectivity over JAK2

被引:0
|
作者
Labadie, Sharada S. [1 ]
机构
[1] Genentech Inc, San Francisco, CA 94080 USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
407-ORGN
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Structure-Based Approaches to Improving Selectivity through Utilizing Explicit Water Molecules: Discovery of Selective β-Secretase (BACE1) Inhibitors over BACE2
    Fujimoto, Kazuki
    Yoshida, Shuhei
    Tadano, Genta
    Asada, Naoya
    Fuchino, Kouki
    Suzuki, Shinji
    Matsuoka, Eriko
    Yamamoto, Takahiko
    Yamamoto, Shiho
    Ando, Shigeru
    Kanegawa, Naoki
    Tonomura, Yutaka
    Ito, Hisanori
    Moechars, Diederik
    Rombouts, Frederik J. R.
    Gijsen, Harrie J. M.
    Kusakabe, Ken-ichi
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (06) : 3075 - 3085
  • [42] Pre-clinical blocking of PD-L1 molecule, which expression is down regulated by NF-κB, JAK1/JAK2 and BTK inhibitors, induces regression of activated B-cell lymphoma
    Christelle Vincent-Fabert
    Lilian Roland
    Ursula Zimber-Strobl
    Jean Feuillard
    Nathalie Faumont
    Cell Communication and Signaling, 17
  • [43] Pre-clinical blocking of PD-L1 molecule, which expression is down regulated by NF-κB, JAK1/JAK2 and BTK inhibitors, induces regression of activated B-cell lymphoma
    Vincent-Fabert, Christelle
    Roland, Lilian
    Zimber-Strobl, Ursula
    Feuillard, Jean
    Faumont, Nathalie
    CELL COMMUNICATION AND SIGNALING, 2019, 17 (01)
  • [44] Structure-based design of oxygen-linked macrocyclic kinase inhibitors: discovery of SB1518 and SB1578, potent inhibitors of Janus kinase 2 (JAK2) and Fms-like tyrosine kinase-3 (FLT3)
    Anders Poulsen
    Anthony William
    Stéphanie Blanchard
    Angeline Lee
    Harish Nagaraj
    Haishan Wang
    Eeling Teo
    Evelyn Tan
    Kee Chuan Goh
    Brian Dymock
    Journal of Computer-Aided Molecular Design, 2012, 26 : 437 - 450
  • [45] Discovery of GlyT2 Inhibitors Using Structure-Based Pharmacophore Screening and Selectivity Studies by FEP plus Calculations
    Fratev, Filip
    Miranda-Arango, Manuel
    Lopez, Ashley Bryan
    Padilla, Elvia
    Sirimulla, Suman
    ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (06): : 904 - 910
  • [46] Structure-based design of oxygen-linked macrocyclic kinase inhibitors: discovery of SB1518 and SB1578, potent inhibitors of Janus kinase 2 (JAK2) and Fms-like tyrosine kinase-3 (FLT3)
    Poulsen, Anders
    William, Anthony
    Blanchard, Stephanie
    Lee, Angeline
    Nagaraj, Harish
    Wang, Haishan
    Teo, Eeling
    Tan, Evelyn
    Goh, Kee Chuan
    Dymock, Brian
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2012, 26 (04) : 437 - 450
  • [47] Platelet-derived growth factor (PDGF)-induced activation of signal transducer and activator of transcription (Stat) 5 is mediated by PDGF β-receptor and is not dependent on c-Src, Fyn, Jak1 or Jak2 kinases
    Paukku, K
    Valgeirsdóttir, S
    Saharinen, P
    Bergman, M
    Heldin, CH
    Silvennoinen, O
    BIOCHEMICAL JOURNAL, 2000, 345 : 759 - 766
  • [48] Structure-based design of C8-substituted O6-alkylguanine CDK1 and 2 inhibitors
    Carbain, B.
    Roche, C.
    Endicott, J. A.
    Golding, B. T.
    Hardcastle, I. R.
    Cano, C.
    Zhen-Wang, L.
    Newell, D. R.
    Noble, M. E. M.
    Griffin, R. J.
    EJC SUPPLEMENTS, 2010, 8 (07): : 140 - 141
  • [49] 2,7-Pyrrolo[2,1-f][1,2,4]triazines as JAK2 inhibitors: Modification of target structure to minimize reactive metabolite formation
    Weinberg, Linda R.
    Albom, Mark S.
    Angeles, Thelma S.
    Breslin, Henry J.
    Gingrich, Diane E.
    Huang, Zeqi
    Lisko, Joseph G.
    Mason, Jennifer L.
    Milkiewicz, Karen L.
    Thieu, Tho V.
    Underiner, Ted L.
    Wells, Gregory J.
    Wells-Knecht, Kevin J.
    Dorsey, Bruce D.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (24) : 7325 - 7330
  • [50] The discovery of potential CDK2-Spy1 inhibitors via structure-based drug design
    Atatreh, N.
    Al Sorkhy, M.
    Al Rawashdah, S.
    Ghattas, M.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E93 - E94